Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
difteri- og tetanustoxoider og acellulær kighostevaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Diphtheria toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
adsorberet tetanus- og difteritoxoid til voksne |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
adsorberet difteri- og tetanustoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
adsorberet tetanustoxoid 20 enheder/ml 0,5 ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure) |
Direct substance |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
difteri-, acellulær kighoste-, hepatitis B- og inaktiveret poliovaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
adsorberet difteri- + tetanus- + kighostevaccine injektionsvæske, hætteglas a 7,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
adsorberet tetanustoxoid 10 enheder til intramuskulær anvendelse, injektionsvæske, suspension, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
adsorberet tetanustoxoid 10 enheder til intramuskulær anvendelse, injektionsvæske, suspension, sprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
adsorberet difteri- + tetanus- + kighostevaccine injektionsvæske, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
tetanus- og difteritoxoid |
Is a |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
tetanustoxoid + reduceret difteritoxoid + acellulær kighostevaccine injektionsvæske, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
tetanus- og difteritoxoid |
Is a |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
adsorberet difteri- og tetanustoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
1 |
rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighostevaccine 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulært kighostetoxoid 25 µg inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighoste-vaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigen 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
tetanustoxoid + reduceret difteritoxoid + acellulær kighostevaccine injektionsvæske, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
difteri- og tetanustoxoider og acellulær kighostevaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
adsorberet tetanus- og difteritoxoid til voksne |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
|
difteri- og tetanustoxoider og helcellekighostevaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
1 |
Vaccine product containing only whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
1 |
Vaccine product containing only Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diphtheria toxoid |
Inferred relationship |
Some |
1 |